Categories: MedicaidNews

The Berwyn Group Announces Mike Schoonveld as General Manager of Strategic Accounts

Schoonveld brings years of industry experience to third-party administrators

INDEPENDENCE, Ohio, March 6, 2025 /PRNewswire/ — The Berwyn Group (Berwyn), the leader in death audit, locate services and population management announces the promotion of Mike Schoonveld to General Manager of the strategic accounts team.

The Berwyn Group offers an end-to-end suite of industry-leading death audit and locate solutions that allow pension and health plan administrators to eliminate costly overpayments, maximize efficiency, meet regulatory requirements, and connect policyholders, participants and beneficiaries to the funds they deserve. Over 2,000 corporate, union and government clients use CertiDeath® and CertiCensus®

“Today third-party administrators (TPA) rely on our solutions to offer their clients a more comprehensive service and solution.  As our business broadens within the TPA segment, we continue to invest in both new solutions and talent to support our clients,” said John Bikus, President of Berwyn. “With extensive years of experience working with clients across all of our industries and understanding the unique value Berwyn brings, Mike is the ideal individual to lead the team dedicated to supporting TPA clients,” said Bikus.

Previously, Schoonveld was the National Director of Sales for The Berwyn Group, managing a team that significantly expanded Berwyn’s market presence and client partnerships. Prior to that role, he held sales and leadership positions at CoStar Group, Thompson Reuters and Micron Technology. 

“I’m excited to continue building upon the strong partnerships we have created and working closely with our clients to further meet their business goals. Berwyn is uniquely positioned to deliver measurable and actionable outcomes to those we serve,” said Schoonveld.

About The Berwyn Group

The Berwyn Group is a leader in population data management, offering the industry’s most trusted and effective death audit and locate solutions, with an unmatched dedication to innovation, security, and generating outcomes. Acquired by Longevity Holdings in 2023, The Berwyn Group now offers an end-to-end suite of industry-leading solutions including CertiDeath® Paragon, CertiDeath®, CertiCensus®, CertiSearch® and BeneSearch®. The Berwyn Group’s mission and focus is making valuable connections to achieve measurable outcomes — bridging the gap between pensions and their participants, insurance companies and their policyholders, third-party administrators and public entities with Medicaid recipients. Connecting leading-edge technology and data with best-in-class human ingenuity, The Berwyn Group helps organizations eliminate costly overpayments, maximize efficiency, meet regulatory requirements, and connect policyholders, participants, and beneficiaries to the funds they deserve. For more information, visit www.berwyngroup.com.

Media Contact: 
Katie Fitzpatrick, Bellmont Partners
katie@bellmontpartners.com
(952) 484-0507

View original content:https://www.prnewswire.com/news-releases/the-berwyn-group-announces-mike-schoonveld-as-general-manager-of-strategic-accounts-302393971.html

SOURCE The Berwyn Group

Staff

Recent Posts

Gargle Launches “Straighten While You…”–A Hyper‑Local Clear Aligner Marketing Platform That Reaches Patients Where They Live Life

LEHI, Utah, Jan. 24, 2026 /PRNewswire/ -- Gargle, Inc., a premier dental marketing partner, officially…

3 hours ago

Ireland Acute Care EHR and Digital Health 2026 Report Released

Black Book Market Research announces an independent, decision grade companion report available gratis to global…

3 hours ago

University Medical Center Southern Nevada Becomes First Hospital in Nevada to Earn Magnet Recognition

Prestigious designation recognizes excellence in nursing, patient care, and clinical outcomesLAS VEGAS, Jan. 24, 2026…

6 hours ago

Direct Meds NAD+ Injections Consumer Report 2026: Comparing Supplement and Peptide Alternatives, Dosage, Benefits & Side Effects

A consumer-focused examination of NAD+ injections, NAD+ supplements, NAD+ peptides, NAD+ dosage protocols, documented NAD+…

6 hours ago

Immunovant to Report Financial Results for the Third Quarter Ended December 31, 2025, and Provide Business Update on Friday, February 6, 2026

DURHAM, N.C. and NEW YORK, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Immunovant (Nasdaq: IMVT) today…

6 hours ago

Nexalin Technology Receives Nasdaq Listing Status Notification

HOUSTON, TX, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL) (the “Company”…

6 hours ago